Anhui Anke Biotechnology (Group) Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 1,076.81 million compared to CNY 966.69 million a year ago. Revenue was CNY 1,080.72 million compared to CNY 969.24 million a year ago.

Net income was CNY 344.44 million compared to CNY 244 million a year ago. Basic earnings per share from continuing operations was CNY 0.21 compared to CNY 0.15 a year ago. Diluted earnings per share from continuing operations was CNY 0.21 compared to CNY 0.15 a year ago.